Abstract 6364: The bispecific antibody KA-3006 against both EGFR and MET surpasses amivantamab in efficacy

Authors: Guojin Wu, Jiabei Liang, Hao Peng, Feng Hao, Tongtong Liu, Jinying Ning

Published: 2024-03-22

DOI: 10.1158/1538-7445.am2024-6364

Source: Full article